about
Recent developments in metabolic bone diseases: a gnathic perspectiveNorisoboldine suppresses osteoclast differentiation through preventing the accumulation of TRAF6-TAK1 complexes and activation of MAPKs/NF-κB/c-Fos/NFATc1 PathwaysThe role of RANK/RANKL/OPG signalling pathways in osteoclastogenesis in odontogenic keratocysts, radicular cysts, and ameloblastomas.RANK/RANKL/OPG signaling pathways in necrotic jaw bone from bisphosphonate-treated subjectsEffect of glucocorticoids on osteoclast function in a mouse model of bone necrosis.Effect of The Receptor Activator of Nuclear Factor кB and RANK Ligand on In Vitro Differentiation of Cord Blood CD133(+) Hematopoietic Stem Cells to Osteoclasts.Effect of breastfeeding on serum osteoprotegerin and soluble receptor activator of nuclear factor-kappa B ligand in full term neonates.The in vitro and in vivo effects of nicotine on bone, bone cells and fracture repair.Osteoprotegerin (OPG) and related proteins (RANK, RANKL and TRAIL) in thyroid disease.Targeting IL-6 and RANKL signaling inhibits prostate cancer growth in bone.Norisoboldine alleviates joint destruction in rats with adjuvant-induced arthritis by reducing RANKL, IL-6, PGE(2), and MMP-13 expression.Pathogenesis of Metastatic Calcification and Acute Pancreatitis in Adult T-Cell Leukemia under Hypercalcemic State.Expression of RANK-ligand in prostate cancer cell lines.Fructus Ligustri Lucidi (FLL) ethanol extract increases bone mineral density and improves bone properties in growing female rats.Serum osteoprotegrin (OPG) and receptor activator of nuclear factor kappaB (RANKL) in healthy children and adolescents.Intermittent PTH(1-34) signals through protein kinase A to regulate osteoprotegerin production in human periodontal ligament cells in vitro.RANK/RANKL/OPG Expression in Rapid Maxillary Expansion.
P2860
Q27012869-D3259C62-8FA6-4F1F-9E03-41D00F1C606BQ34639619-EC51EBA6-3C82-4EE9-8904-9ECB370F51B3Q35214241-A8D312D8-8731-4416-A6C7-F1ADD72C8D1DQ35228787-CEAD4E63-FBBA-4F89-B2DE-342092FC2FAEQ37083062-47420E74-F692-457F-A5D9-C834A50C9B53Q37232005-B769B6AA-F6FF-48B2-BD35-53D9345212F8Q37631987-D959E125-F4EC-4896-919A-645CBA72DB1DQ38081557-E8DD7EA9-C607-4CAB-A7E4-C580B5A696AEQ38409333-DE27A159-AAA5-479C-A34F-AD4F549C161BQ38956445-328382C7-DC19-4862-958A-853C4EC3AC16Q39014536-EAF39D48-7F77-472E-9C28-60FE8C55F431Q39445928-714CF9E9-2E6E-4F20-AF9E-DFA2E741C96BQ39908561-768DBDAF-29F4-4078-A460-607E887F1CC0Q44646270-6C6F4F09-706A-4F5E-B11A-88479CD1B4E3Q45929205-F8D71609-5DEE-43EE-94F9-A811645975BBQ46440419-B0A698D8-401E-4462-B1FB-9F1D278D52DAQ47215322-05607E49-A758-4493-B477-03B27CACEE84
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
RANK ligand.
@ast
RANK ligand.
@en
type
label
RANK ligand.
@ast
RANK ligand.
@en
prefLabel
RANK ligand.
@ast
RANK ligand.
@en
P2093
P1476
RANK ligand.
@en
P2093
P304
P356
10.1016/J.BIOCEL.2006.11.008
P577
2006-11-23T00:00:00Z